Brief: Pacira Biosciences Reports Fourth Quarter And Full-Year 2025 Financial Results

Pacira BioSciences

26/02/2026 23:20

Feb 27 (Reuters) - Pacira Biosciences Inc PCRX.O:

PACIRA BIOSCIENCES REPORTS FOURTH QUARTER AND FULL-YEAR 2025 FINANCIAL RESULTS

PACIRA BIOSCIENCES FY ADJUSTED EBITDA USD 186.5 MILLION VS. IBES ESTIMATE USD 204 MILLION

PACIRA BIOSCIENCES FY NET INCOME USD 7 MILLION

PACIRA BIOSCIENCES FY ADJUSTED NET INCOME USD 122.3 MILLION VS. IBES ESTIMATE USD 139.8 MILLION

PACIRA BIOSCIENCES INC - OUTLOOK 2026 TOTAL REVENUE OF $745 MILLION TO $770 MLN

Source text: ID:nGNX2vzVBn

Further company coverage: PCRX.O

 ((Reuters.Briefs@thomsonreuters.com;))